Curaleaf Holdings, Inc. (OTCMKTS:CURLF) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of Curaleaf Holdings, Inc. (OTCMKTS:CURLF – Get Rating) have been assigned an average recommendation of “Moderate Buy” from the eleven brokerages that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $10.00.

A number of equities analysts recently weighed in on the company. Alliance Global Partners dropped their price target on Curaleaf from $11.00 to $8.00 and set a “buy” rating on the stock in a research note on Friday, April 14th. Wedbush reissued an “outperform” rating and issued a $8.50 price target on shares of Curaleaf in a research note on Friday, April 14th. Stifel Nicolaus dropped their price target on Curaleaf from C$8.50 to C$8.00 in a research note on Wednesday, February 8th. Finally, Benchmark lowered Curaleaf from a “buy” rating to a “hold” rating in a research report on Friday, May 19th.

Get Curaleaf alerts:

Curaleaf Price Performance

OTCMKTS:CURLF opened at $2.80 on Wednesday. The business’s 50-day moving average price is $2.63 and its 200 day moving average price is $3.72. The firm has a market cap of $1.75 billion and a P/E ratio of -5.19. Curaleaf has a 52-week low of $2.19 and a 52-week high of $7.90. The company has a quick ratio of 0.62, a current ratio of 1.10 and a debt-to-equity ratio of 0.73.

Curaleaf (OTCMKTS:CURLF – Get Rating) last issued its quarterly earnings results on Wednesday, May 17th. The company reported ($0.05) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.05). The firm had revenue of $336.50 million for the quarter, compared to analysts’ expectations of $332.21 million. Curaleaf had a negative return on equity of 20.37% and a negative net margin of 28.88%. As a group, sell-side analysts predict that Curaleaf will post -0.17 earnings per share for the current fiscal year.

Curaleaf Company Profile

(Get Rating)

Curaleaf Holdings, Inc operates as a holding company with interest in medical and wellness cannabis operations. It operates through the Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment includes the production and sale of cannabis via retail and wholesale channels.

Featured Stories

• Get a free copy of the StockNews.com research report on Curaleaf (CURLF)
• Is American Airlines a Good Stock to Buy?
• High Dividend REITs: Are They an Ideal Way to Diversify?
• It Is Not Too Late To “Git” On Board With GitLab 
• Is Frontline’s 20% Dividend Too Good To Be True?
• Hospitality’s Rebound Has A Table At Cracker Barrel

Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.